Clinical Trial Update: A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for TQB3107 tablets in patients with advanced cancers; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TQB3107

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Cancers | Phase 1 | Status: RECRUITING